Skip to main content

Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. A new method for monitoring heparin therapy.

Ansell J, Tiarks C, Hirsh J, McGehee W, Adler D, Weibert R

Publication: Am J Clin Pathol (1991) • Vol 95 • Page 222-7PMID: 1992612View on PubMed

Purpose

The purpose of this paper was to determine the effects of using capillary (whole blood) versus venous (plasma and whole blood) specimens, method of measurement, and type of auto analyzer reagents on activated partial thromboplastin time (aPTT) measurements.

Conclusion

aPTT measurements from capillary whole blood and venous whole blood measured on the portable 512 Coagulation Monitor were very strongly correlated. Strong correlations were also observed between capillary blood aPTT measured by the portable instrument and venous plasma aPTT measured using standard methods, regardless of reagent type. Further, a strong correlation was seen between plasma aPTT measured using two types of reagents.

Studies (1)

Purpose

The purpose of this study was to determine the effects of using capillary (whole blood) versus venous (plasma and whole blood) specimens, method of measurement, and type of auto analyzer reagents on aPTT in specimens from patients on anticoagulant therapy and normal controls. Venous blood to be used for standard plasma aPTT measurement was placed on ice for an undisclosed amount of time prior to centrifugation.

Summary of Findings

aPTT measurements from capillary whole blood and venous whole blood measured on the portable 512 Coagulation Monitor were very strongly correlated (r=0.93). Strong correlations were also observed between capillary blood aPTT measured by the portable instrument and venous plasma aPTT measured using standard analyzers and either Dade Actin FS reagents or General Diagnostics reagents (r=0.79-0.83). Further, a strong correlation was seen between plasma aPTT measured using both types of reagents (r=0.79). Hematocrit had no effect on venous whole blood aPTT measured by the portable monitor, and the authors state that platelet counts also had no correlation with aPTT.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Other diagnoses
  • Platforms

    MorphologyHematology/ auto analyzer
    Cell count/volumeHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Receiving heparin and/or warfarin anticoagulation therapy
    Biospecimen AcquisitionAnatomical location of blood draw
    Capillary
    Vein
    Biospecimen AcquisitionMethod of fluid acquisition
    Finger/heel prick sampling
    Venipuncture
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Whole blood
    Hematology/ auto analyzer SpecificReaction solution
    Dade Actin FS reagents
    General Diagnostics reagents
    Hematology/ auto analyzer SpecificTechnology platform
    512 Coagulation Monitor (portable)
    MLA 700
    MLA 750